• Explore /
  • Poster
  • / Targeted therapy for advanced salivary cancer with HER2 or hedgehog alterations: Interim data from MyPathway.

Targeted therapy for advanced salivary cancer with HER2 or hedgehog alterations: Interim data from MyPathway.

Abstract Poster

Authors

null

Razelle Kurzrock

Moores Cancer Center, University of California San Diego School of Medicine, San Diego, CA

Razelle Kurzrock , Funda Meric-Bernstam , Herbert Hurwitz , John D. Hainsworth , David R. Spigel , Ron Bose , Charles Swanton , Howard A. Burris III, Christopher Sweeney , Bongin Yoo , Mary Stanley Beattie , Rajesh Patel , Katja Schulze , Elaine Tat Lam

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Other Head and Neck Cancer (Salivary, Thyroid)

Clinical Trial Registration Number

NCT02091141

Citation

J Clin Oncol 35, 2017 (suppl; abstr 6086)

DOI

10.1200/JCO.2017.35.15_suppl.6086

Abstract #

6086

Poster Bd #

74

Abstract Disclosures

Similar Posters

First Author: John D. Hainsworth

First Author: Herbert Hurwitz

First Author: Howard A. Burris III

First Author: Lotte Maria Gertruda Steuten